BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32842026)

  • 41. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
    Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
    Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abundance of CD163-Positive Tumor-Associated Macrophages in the Early Gastric Cancer Predicts the Recurrence after Curative Resection.
    Zhou W; Zhang Y; He F; Lv S; Zhang X; Fei C
    Dig Dis; 2020; 38(6):458-465. PubMed ID: 32721976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD163
    Omilian AR; Cannioto R; Mendicino L; Stein L; Bshara W; Qin B; Bandera EV; Zeinomar N; Abrams SI; Hong CC; Yao S; Khoury T; Ambrosone CB
    Breast Cancer Res; 2024 May; 26(1):75. PubMed ID: 38720366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer.
    Corvigno S; Mezheyeuski A; De La Fuente LM; Westbom-Fremer S; Carlson JW; Fernebro J; Åvall-Lundqvist E; Kannisto P; Hedenfalk I; Malander S; Rolny C; Dahlstrand H; Östman A
    Gynecol Oncol; 2020 Dec; 159(3):860-868. PubMed ID: 33032823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer.
    Jackute J; Zemaitis M; Pranys D; Sitkauskiene B; Miliauskas S; Vaitkiene S; Sakalauskas R
    BMC Immunol; 2018 Jan; 19(1):3. PubMed ID: 29361917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma.
    Komohara Y; Niino D; Saito Y; Ohnishi K; Horlad H; Ohshima K; Takeya M
    Cancer Sci; 2013 Jul; 104(7):945-51. PubMed ID: 23557330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of PFKFB3 and CD163 in Oral Squamous Cell Carcinoma Angiogenesis.
    Li JJ; Mao XH; Tian T; Wang WM; Su T; Jiang CH; Hu CY
    Curr Med Sci; 2019 Jun; 39(3):410-414. PubMed ID: 31209811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of M2-macrophages in uveal melanoma and relation with survival.
    Bronkhorst IH; Ly LV; Jordanova ES; Vrolijk J; Versluis M; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):643-50. PubMed ID: 20811059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The increased number of tumor-associated macrophage is associated with overexpression of VEGF-C, plays an important role in Kazakh ESCC invasion and metastasis.
    Hu JM; Liu K; Liu JH; Jiang XL; Wang XL; Yang L; Chen YZ; Liu CX; Li SG; Cui XB; Zou H; Pang LJ; Zhao J; Qi Y; Liang WH; Yuan XL; Li F
    Exp Mol Pathol; 2017 Feb; 102(1):15-21. PubMed ID: 27939650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer.
    Hu H; Hang JJ; Han T; Zhuo M; Jiao F; Wang LW
    Tumour Biol; 2016 Jul; 37(7):8657-64. PubMed ID: 26738860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraepithelial CD163
    Shigeoka M; Koma YI; Kodama T; Nishio M; Akashi M; Yokozaki H
    Oral Dis; 2020 Apr; 26(3):527-536. PubMed ID: 31886947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer.
    Xu G; Jiang L; Ye C; Qin G; Luo Z; Mo Y; Chen J
    Front Immunol; 2021; 12():724429. PubMed ID: 34512652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma.
    Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK
    J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
    Meehan K; Leslie C; Lucas M; Jacques A; Mirzai B; Lim J; Bulsara M; Khan Y; Wong NC; Solomon B; Sader C; Friedland P; Mir Arnau G; Semple T; Lim AM
    Cancer Med; 2020 Jul; 9(13):4791-4807. PubMed ID: 32383556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumour-associated macrophages are recruited and differentiated in the neoplastic stroma of oral squamous cell carcinoma.
    Essa AA; Yamazaki M; Maruyama S; Abé T; Babkair H; Raghib AM; Megahed EM; Cheng J; Saku T
    Pathology; 2016 Apr; 48(3):219-27. PubMed ID: 27020496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD163-Positive Macrophages Within the Tumor Stroma Are Associated With Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Yamagata Y; Tomioka H; Sakamoto K; Sato K; Harada H; Ikeda T; Kayamori K
    J Oral Maxillofac Surg; 2017 Oct; 75(10):2144-2153. PubMed ID: 28399391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlations of tumor-associated macrophage subtypes with liver metastases of colorectal cancer.
    Cui YL; Li HK; Zhou HY; Zhang T; Li Q
    Asian Pac J Cancer Prev; 2013; 14(2):1003-7. PubMed ID: 23621176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Young and elderly oral squamous cell carcinoma patients present similar angiogenic profile and predominance of M2 macrophages: Comparative immunohistochemical study.
    Teixeira LR; Almeida LY; Silva RN; Mesquita ATM; Colturato CBN; Silveira HA; Duarte A; Ribeiro-Silva A; León JE
    Head Neck; 2019 Dec; 41(12):4111-4120. PubMed ID: 31497915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC.
    Ohri CM; Shikotra A; Green RH; Waller DA; Bradding P
    PLoS One; 2011; 6(7):e21874. PubMed ID: 21799753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.
    Sugimura K; Miyata H; Tanaka K; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    J Surg Oncol; 2015 May; 111(6):752-9. PubMed ID: 25752960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.